Eisai

4523.TSE

28.54 USD

-0.47

-1.62%

Overview

Last close

28.54 usd

Market cap

8.05B usd

52 week high

42.10 usd

52 week low

24.09 usd

Target price

31.18 usd

Valuation

P/E

25.6407

Forward P/E

32.6797

Price/Sales

1.5719

Price/Book Value

1.4799

Enterprise Value

7.63B usd

EV/Revenue

1.4905

EV/EBITDA

10.8932

Key financials

Revenue TTM

5.12B usd

Gross Profit TTM

4.01B usd

EBITDA TTM

591.78M usd

Earnings per Share

1.11 usd

Dividend

1.02 usd

Total assets

9.73B usd

Net debt

-439.51M usd

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.